What is the Price of Xeljanz?
The average retail price for Xeljanz (tofacitinib) 5 mg tablets is approximately $5,500 to $6,000 for a 30-day supply [1]. This price reflects the cost without insurance or discount programs [1].
How Can I Reduce the Cost of Xeljanz?
Several options exist to potentially lower the out-of-pocket cost of Xeljanz. Pfizer, the manufacturer, offers a Xeljanz Savings Card that can reduce co-pays for eligible commercially insured patients, sometimes bringing the monthly cost down to as low as $5 [2]. For those without commercial insurance, other patient assistance programs may be available [2]. Your healthcare provider can also discuss options for financial assistance [1].
What is Tofacitinib and What is it Used For?
Xeljanz is the brand name for tofacitinib, a Janus kinase (JAK) inhibitor medication [3]. It is prescribed to treat adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who have had an inadequate response or intolerance to other treatments [3].
When Does the Xeljanz Patent Expire?
Patent expiry dates are crucial for the potential introduction of lower-cost generic versions. Information regarding specific patent expiries for Xeljanz can be found through resources like DrugPatentWatch.com [4]. These dates can be complex, involving multiple patents and potential legal challenges that may affect generic market entry timelines [4].
How Does Xeljanz Compare to Other Arthritis Medications?
Xeljanz belongs to a class of drugs known as JAK inhibitors, which work differently from traditional disease-modifying antirheumatic drugs (DMARDs) like methotrexate or biologic DMARDs [3]. While other medications target specific parts of the immune system, JAK inhibitors affect intracellular signaling pathways involved in inflammation [3]. Comparisons often focus on efficacy, safety profiles, and administration routes [3].
What Are the Potential Side Effects of Xeljanz?
Xeljanz carries a boxed warning regarding serious infections, including tuberculosis and invasive fungal infections, as well as an increased risk of death, heart attack, stroke, blood clots, and certain cancers [3]. Other potential side effects include upper respiratory tract infections, headache, and diarrhea [3]. Patients are advised to discuss all potential risks with their doctor [3].
Are There Generic Versions of Xeljanz Available?
As of current information, generic versions of tofacitinib are not widely available on the market [4]. The introduction of generics typically follows patent expiry, and any ongoing patent litigation can impact this timeline [4].
Where Can I Find More Information on Drug Pricing and Patents?
For detailed information on drug pricing, patent status, and potential generic availability, resources like DrugPatentWatch.com provide valuable data [4].
---
Sources:
[1] https://www.drugpatentwatch.com/drug/xeljanz
[2] https://www.xeljanz.com/savings-and-support.html
[3] https://www.xeljanz.com/about-xeljanz/what-is-xeljanz.html
[4] https://www.drugpatentwatch.com/